PHA.PA
Pharmagest Interactive SA
Price:  
81.90 
EUR
Volume:  
2,580.00
France | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PHA.PA WACC - Weighted Average Cost of Capital

The WACC of Pharmagest Interactive SA (PHA.PA) is 7.4%.

The Cost of Equity of Pharmagest Interactive SA (PHA.PA) is 7.60%.
The Cost of Debt of Pharmagest Interactive SA (PHA.PA) is 5.00%.

Range Selected
Cost of equity 6.30% - 8.90% 7.60%
Tax rate 31.00% - 31.60% 31.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.1% - 8.6% 7.4%
WACC

PHA.PA WACC calculation

Category Low High
Long-term bond rate 2.6% 3.1%
Equity market risk premium 5.2% 6.2%
Adjusted beta 0.71 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 8.90%
Tax rate 31.00% 31.60%
Debt/Equity ratio 0.06 0.06
Cost of debt 5.00% 5.00%
After-tax WACC 6.1% 8.6%
Selected WACC 7.4%

PHA.PA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for PHA.PA:

cost_of_equity (7.60%) = risk_free_rate (2.85%) + equity_risk_premium (5.70%) * adjusted_beta (0.71) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.